Literature DB >> 33503954

Diagnosis and Treatment of Primary and Secondary Lung Cancers.

Francesco Petrella1,2.   

Abstract

Primary and secondary lung cancers are the most common clinical conditions that thoracic surgeons have to deal with: primary lung cancer, in fact, is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide [...].

Entities:  

Year:  2021        PMID： 33503954      PMCID： PMC7865761          DOI： 10.3390/cancers13030448

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  13 in total

1.  Predicting prolonged air leak after standard pulmonary lobectomy: computed tomography assessment and risk factors stratification.

Authors:  Francesco Petrella; Stefania Rizzo; Davide Radice; Alessandro Borri; Domenico Galetta; Roberto Gasparri; Piergiorgio Solli; Giulia Veronesi; Massimo Bellomi; Lorenzo Spaggiari
Journal:  Surgeon       Date:  2010-08-23       Impact factor: 2.392

2.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Authors:  U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  1997-01       Impact factor: 5.209

3.  Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.

Authors:  Monica Casiraghi; Patrick Maisonneuve; Gaia Piperno; Roberto Bellini; Daniela Brambilla; Francesco Petrella; Filippo De Marinis; Lorenzo Spaggiari
Journal:  Semin Thorac Cardiovasc Surg       Date:  2017-02-24

4.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

5.  Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma.

Authors:  Teruya Kawamoto; Hitomi Hara; Masayuki Morishita; Naomasa Fukase; Yohei Kawakami; Toshiyuki Takemori; Shuichi Fujiwara; Kazumichi Kitayama; Shunsuke Yahiro; Tomohiro Miyamoto; Takuya Fujimoto; Ikuo Fujita; Kenichiro Kakutani; Tomoyuki Matsumoto; Takehiko Matsushita; Takahiro Niikura; Ryosuke Kuroda; Toshihiro Akisue
Journal:  Clin Exp Metastasis       Date:  2020-05-20       Impact factor: 5.150

6.  A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme.

Authors:  Giuseppe Pelosi; Francesco Petrella; Maria Teresa Sandri; Lorenzo Spaggiari; Domenico Galetta; Giuseppe Viale
Journal:  Int J Surg Pathol       Date:  2006-07       Impact factor: 1.271

7.  Which factors affect pulmonary function after lung metastasectomy?

Authors:  Francesco Petrella; Pasquale Chieco; Piergiorgio Solli; Giulia Veronesi; Alessandro Borri; Domenico Galetta; Roberto Gasparri; Lorenzo Spaggiari
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-23       Impact factor: 4.191

Review 8.  Pulmonary metastasectomy: an overview.

Authors:  Francesco Petrella; Cristina Diotti; Arianna Rimessi; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

9.  Multiple chondromatous hamartomas of the lung.

Authors:  A Bini; M Grazia; F Petrella; M Chittolini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2002-12

10.  Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Motoshi Takao; Atsuhiro Nakatsuka; Takao Matsubara; Kunihiro Asanuma; Akihiro Sudo
Journal:  Onco Targets Ther       Date:  2017-01-31       Impact factor: 4.147
View more
  1 in total

1.  Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.

Authors:  Norman R Williams; Hannah Patrick; Francesca Fiorentino; Alexander Allen; Manuj Sharma; Mišel Milošević; Fergus Macbeth; Tom Treasure
Journal:  Eur J Cardiothorac Surg       Date:  2022-06-15       Impact factor: 4.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.